RXi Pharmaceuticals Profile

0.61
USD 0.0449  7.95%
0.44Last Month High 0.61 
0.55Trading Day  High 0.68 

RXi Pharmaceuticals exotic insider transaction detected

RXi Pharmaceuticals Corporation insider trading alert for general transaction of common stock $0.0001 par value by Geert Cauwenbergh, President CEO, on October 2, 2017. This event was filed by Rxi Pharmaceuticals Corp with SEC on 2017-10-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

RXi Pharmaceuticals Summary

RXi Pharmaceuticals Corporation (RXII) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 16 people. RXi Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 12.04 M. RXi Pharmaceuticals Corporation has 23.7 M outstanding shares of which 2.16 M shares are at this time shorted by private and institutional investors with about 7.01 trading days to cover. RXI PHARMACEUTICA currently holds about 7.7 M in cash with (8.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Check RXi Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Susquehanna International Group LlpWarrants2.2 M400 K
Panagora Asset Management IncCommon Shares85.3 K50 K
Kcg Holdings IncCommon Shares77.3 K45 K
View RXi Pharmaceuticals Diagnostics

Selected RXi Pharmaceuticals Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

RXi Pharmaceuticals Against Markets

Risk Adjusted
Performance Score (0 to 100)
14 
Chance of
< 71% 
RXi Pharmaceuticals Corporationration, a clinicalstage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameRXi Pharmaceuticals Corporation
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMASSACHUSETTS, U.S.A
Business AddressMarlborough, MA
ExchangeNasdaq Capital Markets
CUSIP74979C303
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.rxipharma.com
Contact Number508 767 3861
CurrencyUSD - US Dollar

Recommendations

RXi Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
8.0Strong Buy1Odds
RXi Pharmaceuticals Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
RXi Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

RXi Pharmaceuticals Earnings Estimates
RXi Pharmaceuticals Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate